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There is increasing academic and clinical interest in how “lifestyle factors” traditionally 
associated with physical health may also relate to mental health and psychological well-being. 
In response, international and national health bodies are producing guidelines to address 
health behaviors in the prevention and treatment of mental illness. However, the current 
evidence for the causal role of lifestyle factors in the onset and prognosis of mental disorders 
is unclear. We performed a systematic meta-review of the top-tier evidence examining how 
physical activity, sleep, dietary patterns and tobacco smoking impact on the risk and treatment 
outcomes across a range of mental disorders. Results from 29 meta-analyses of 
prospective/cohort studies, 12 Mendelian randomization studies, and 2 meta-reviews, and 2 
meta-analyses of randomized controlled trials were synthesized to generate overviews of the 
evidence for targeting each of the specific lifestyle factors in the prevention and treatment of 
depression, anxiety and stress-related disorders, schizophrenia, bipolar disorder, and 
attention-deficit/hyperactivity disorder. Standout findings include: a) convergent evidence 
indicating the use of physical activity in primary prevention and clinical treatment across a 
spectrum of mental disorders; b) emerging evidence implicating tobacco smoking as a causal 
factor in onset of both common and severe mental illness; c) the need to clearly establish 
causal relations between dietary patterns and risk of mental illness, and how diet should be 
best addressed within mental health care; and d) poor sleep as a risk factor for mental illness, 
although with further research required to understand the complex, bidirectional relations and 
the benefits of non-pharmacological sleep-focused interventions. The potentially shared 
neurobiological pathways between multiple lifestyle factors and mental health are discussed, 
along with directions for future research, and recommendations for the implementation of 
these findings at public health and clinical service levels. 
 
Key words: Lifestyle factors, mental disorders, psychological well-being, physical activity, 
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Mental disorders affect almost 30% of individuals across the lifespan1, and are among the 
largest contributors to the global burden of disease, accounting for 32% of all years lived with 
disability, and 13% of disability-adjusted life years2. Despite many advances in 
psychotherapies and pharmacological treatments for a range of psychiatric conditions, there 
remains a substantial proportion of individuals who do not achieve full remission from standard 
treatment3,4. Additionally, a large portion of the global population do not have access to 
traditional mental health care, due to the scarcity of psychiatric services available, particularly 
in many low- and middle-income countries3,5. There has also been little improvement in 
primary prevention of mental illness, with clear gaps in both the evidence and implementation 
for such interventions6. Indeed, rates of common mental disorders (i.e., depression and 
anxiety) appear to even be increasing among the younger generations7. Thus, new 
approaches towards the prevention and treatment of mental illness, which can be delivered 
alongside or in the absence of traditional mental health care, are needed to reduce the global 
and growing burden of these conditions. 
An emerging body of research has linked both the onset and symptoms of various mental 
disorders to “lifestyle factors”, a term referring to health behaviors such as physical activity, 
diet, tobacco smoking and sleep8. For instance, a mass of cross-sectional evidence9 shows 
that a range of psychiatric conditions (including schizophrenia, bipolar disorder, depression, 
and anxiety and stress-related disorders) are associated with adverse health behaviors, such 
as poorer dietary and sleeping patterns, low levels of physical activity, and higher rates of 
tobacco smoking, compared to healthy controls. Additionally, recent findings from population-
scale studies document that the relationships between many of these lifestyle risk factors and 
mental illness also persist in low- and middle-income countries10-12.  
Although useful, this expansive body of cross-sectional research does not uncover the 
causality of the observed relationships. Therefore, the evidence for which lifestyle factors 
should be addressed when aiming to prevent the onset of mental illness, or reduce symptoms 
in those with established conditions, is currently very limited.  
Nonetheless, a number of national health policy documents and clinical guidelines are 
now beginning to address the role of specific lifestyle factors in the prevention and treatment 
of mental illness. For instance, both the US Physical Activity Guidelines for Americans13 and 
the UK Chief Medical Officers' Physical Activity Guidelines14 recommend attaining at least 150 
min of moderate-to-vigorous physical activity per week for reducing the risk of depression 
(including postnatal depression).  
In order to preserve both overall mental health and cognitive functioning, both Canada’s15 
and Australia’s16 24-Hour Movement Guidelines have adopted a “whole day time-use” 




moderate-to-vigorous exercise, several hours of light physical activity, no more than two hours 
of sedentary leisure activities, and 8-11 hours of uninterrupted sleep. The UK Royal College 
of Psychiatrist’s position statement on public mental health6 also describes how the clustering 
of health-risk behaviours (which include smoking, lack of exercise, and unhealthy eating) 
increases lifetime risk of mental illness. 
Along with this surge of recognition from public health perspectives, the role of behavioral 
factors is also becoming a topic of increasing interest in psychiatric research and mental health 
services. Notably, the European Psychiatric Association’s guidelines17 on physical activity in 
mental illness put forth that there is sufficient evidence to recommend structured exercise 
training as an effective first-line treatment option for moderate depression, and as an 
adjunctive intervention for improving symptomatic recovery in severe mental illness. 
Additionally, the Royal Australian and New Zealand College of Psychiatrists’ clinical practice 
guidelines for mood disorders18 list exercise, smoking, diet and sleep as “step zero” targets, 
to be addressed before implementation of pharmacotherapy and/or psychotherapy. 
There are a large number of individual clinical trials, epidemiological studies, and meta-
analyses investigating the impact of other health behaviors in various psychiatric conditions. 
However, existing guidelines predominantly focus on physical activity, and typically only in 
relation to depression or schizophrenia. The broader role of lifestyle factors, across the 
spectrum of mental disorders, has yet to be established.  
This meta-review aimed to establish the current evidence on causal relations between 
key modifiable health behaviors (physical activity, dietary food intake, tobacco smoking, and 
sleep) with the incidence and outcomes of major mental disorders, including depression, 
anxiety and stress-related disorders, attention-deficit/hyperactivity disorder (ADHD), bipolar 
disorder, schizophrenia and related psychotic disorders. We sought to present an empirical 
overview of the field of lifestyle medicine for mental illness, and produce evidence-based 
recommendations for targeting modifiable health behavior factors in the prevention and 






This meta-review aimed to systematically aggregate the most recent, top-tier evidence for 
the role of “lifestyle factors” in the prevention and treatment of mental disorders, following the 
PRISMA statement to ensure comprehensive and transparent reporting19. The systematic 
searches were conducted on February 3, 2020 of the following databases: Allied and 




Information Consortium, EMBASE and the NHS Economic Evaluation and Health Technology 
Assessment databases.  
The following PICOS search algorithm was used: Participants [‘mental health or 
psychological well-being or psychological outcomes or mental well-being or psychiat* or 
mental illness* or mental disorder* or depress* or mood disorder* or affective disorder* or 
anxi* or panic or obsessive compulsive or OCD or ADHD or attention deficit or attentional 
deficit or phobi* or bipolar type or bipolar disorder* or psychosis or psychotic or schizophr* or 
schizoaffective or antipsychotic* or post traumatic* or personality disorder* or stress disorder* 
or dissociative disorder or antidepress* or antipsychotic*’.ti]; Interventions/Exposures 
[physical activity or exercis* or sport* or walking or intensity activity or resistance training or 
muscle or sedentary or screen time or screentime or aerobic or fitness or diet* or nutri* or 
food* or vegan or vege* or meat or carbohy* or fibre or sugar* or adipos* or vitamin* or fruit* 
or sleep* or insomn* or circad* or smoke* or smoking or tobacco or nicotine or healthy or obes* 
or weight or bodyweight or body mass or BMI or health behav* or behavior change or behavior 
change or lifestyle*.ti]; Outcomes [‘meta-analy* or metaanaly* or meta reg* or metareg* or 
systematic review* or Mendel* or meta-review or reviews or umbrella review or updated 
review*’.ti]; Study design [‘prospective or protect* or inciden* or onset or prevent* or cohort or 
predict* or risk or longitudinal or randomized or randomised or mendel* or bidirectional or 
controlled or trial* or causal’].  
Separate searches of the Cochrane Database of Systematic Reviews and Google Scholar 




The lifestyle factors examined were those pertaining to physical activity, diet, sleep and 
smoking. 
“Physical activity” was considered in the broadest sense, including overall physical activity 
levels, structured exercise training interventions, and also studies examining the absence of 
physical activity, i.e. sedentary behavior. “Diet” focused on dietary food intake/interventions, 
and did not include studies evaluating specific nutrient treatments (as these have been already 
reviewed extensively in this journal20) or those examining blood levels of individual 
vitamins/minerals/fatty acids (as blood levels of these nutrients are influenced by many genetic 
and environmental factors, independent from dietary intake21,22). “Sleep” was examined as 
general sleep patterns, quality or quantity, along with studies examining either the impact of 
sleep disorders (i.e., insomnia) on risk of mental illnesses, or the efficacy of non-
pharmacological interventions directly targeting sleep to improve psychiatric symptoms. The 




passive exposure, rather than illicit drugs, as the known psychoactive effects of these latter 
substances have been reviewed extensively in this journal23. 
Mental disorders eligible to be included in this meta-review were mood disorders 
(moderate or severe depression, or bipolar disorder), psychotic disorders (including 
schizophrenia and related conditions), anxiety and stress-related disorders, dissociative 
disorders, personality disorders, and ADHD. We excluded psychiatric conditions which are 
directly characterized by adverse health behaviors (i.e., eating disorders and alcohol or 
substance use disorders) along with other neurodevelopmental disorders (e.g., autism, 
intellectual disability) and neurodegenerative disorders (e.g., dementia), as these were 
considered beyond the scope of this review.  
Protective factors were examined using two sources of data. First, we searched for meta-
analyses of longitudinal data that examined relationships between the various lifestyle factors 
and prospective risk/onset of mental illness. Eligible meta-analyses were those presenting 
suitable quantitative data - as adjusted or raw odds ratios (ORs), risk ratios (RRs) or hazard 
ratios (HRs) – on how baseline status of behavioral variables influences the prospective risk 
of mental illness, including diagnosed psychiatric conditions, clinically significant symptoms 
(using established cut-offs on validated screening instruments), or based on percentile cut-
offs of psychiatric symptom scores.  
The second source of data used for examining protective factors were any Mendelian 
randomization (MR) studies of the link between lifestyle factors and mental illness. Briefly, MR 
is a causal inference method that can be used to estimate the effect of an exposure (X) on an 
outcome (Y) whilst minimizing bias from confounding and reverse causation24,25. Suitable 
genetic instruments (usually single nucleotide polymorphisms, SNPs) are identified through 
genome-wide association studies (GWAS). Individuals carrying the effect allele of the variant 
have higher (or lower) levels of X on average than those without the effect alleles. Following 
Mendel’s laws of segregation and independent assortment, the genetic variants are inherited 
randomly at conception, and are inherited independently of confounding lifestyle factors26. 
Therefore, MR can be considered somewhat analogous to a randomized controlled trial (RCT) 
of behavioral factors in the prevention of mental illness, as genetic variants randomly 
predispose individuals to experience different levels of these factors26. As genes also remain 
unchanged throughout the life course, they are also not altered by the outcome of interest, 
thus reducing bias from reverse causation26. Therefore, while meta-analyses of prospective 
cohort studies are useful for identifying the overall strength and directionality of associations, 
the MR analyses were used to further infer the causal nature of the observed relationships.  
The evidence for lifestyle interventions in the treatment of people with diagnosed mental 
disorders was examined using two different sources of data, but both based on meta-analyses 




we searched for existing meta-reviews of meta-analyses of RCTs published in the last five 
years, for each lifestyle factor, providing quantitative effects of physical activity, diet, smoking 
cessation or non-pharmacological sleep interventions on psychiatric symptoms in people with 
mental illness. Second, for the lifestyle factors that were not covered within the existing meta-
reviews, we sought out meta-analyses of RCTs examining their impact (using the search 
strategy above), and synthesized the evidence from the meta-analyses using a methodology 
derived from a previous meta-review20. For meta-analyses with mixed samples, only those in 
which at least 75% of the sample examined the eligible mental illnesses (as described above) 




A systematic tool was applied to each eligible meta-analysis/MR study to extract the 
relevant data on the association of lifestyle factors with risk of mental illness, or the effects of 
lifestyle interventions on psychiatric outcomes. Results of eligible meta-reviews were 
extracted narratively, summarised from their respective articles. 
For meta-analyses of longitudinal studies, the strength and direction of the prospective 
associations between lifestyle factors and mental illness was quantified categorically, and thus 
extracted as ORs, HRs or RRs, with 95% confidence intervals (CIs).  
For meta-analyses of RCTs of lifestyle interventions in mental illness, effect size data 
were quantified as a continuous variable (i.e., magnitude of effect on psychiatric symptoms) 
and thus extracted as standardized mean differences (SMDs), Cohen’s d or Hedges’ g. These 
were then classified as small (<0.4), moderate (0.4-0.8), or large (>0.8). 
For all meta-analyses, data on the degree of between-study heterogeneity (quantified as 
I² values) were also extracted, where reported. 
In cases where multiple eligible meta-analyses examined a specific lifestyle factor in the 
risk/treatment of the same mental disorder were found, the most recent was used 
preferentially. Where older meta-analyses featured >25% more studies than the newer 
versions and contained important, novel findings from unique analyses not captured in the 
most recent versions, these were also extracted and presented alongside the newer findings. 
In cases where two MR studies had examined the same lifestyle factor for the same mental 
health outcome, both studies (regardless of recency or sample size) were included and 
reviewed. 
We also extracted relevant study characteristics where reported, including number of 
pooled comparisons within meta-analyses (n), sample size (N), details on the specifics of 
lifestyle exposure or intervention examined, and sample features. The results of key 




examined, or different types of exposure/interventions, modified the effect of the specific 
lifestyle factor were extracted as well. For the purposes of providing a concise summary of the 
literature, only the findings from secondary analyses which provided important, unique insights 
into the evidence were extracted.  
 
Quality assessment of included studies 
 
The National Institutes of Health (NIH)’s Quality Assessment Tool for Systematic Reviews 
and Meta-Analyses was used to assess the quality of the included meta-analyses. This tool 
evaluates the quality of meta-analyses rating them for adequacy of the search question, 
specification of inclusion and exclusion criteria, systematic search, screening of papers, 
quality assessment and summaries of included studies, and tests for publication bias and 
heterogeneity. In accordance with previous meta-reviews using the NIH tool27, the quality of 
included meta-analyses was categorized as “good” (7 or 8), “fair” (4-6), or “poor” (0-3). 
As no consensus tool exists for determining the quality of MR and meta-review studies, 







The main search returned a total of 1,811 results, which were reduced to 834 after 
duplicates were excluded. A total of 92 full text papers were retrieved, from which 41 met full 
inclusion criteria. Of note, one seemingly eligible study28 was excluded for invalid findings due 
to inconsistent coding of effect directionality. Four additional studies were identified from the 
supplementary searches, and thus 45 studies were included in total. Across the different 
lifestyle factors, 11 of the eligible papers focused on physical activity/exercise, 15 were on 
smoking, 12 examined diet, and 10 considered sleep. Some papers covered multiple factors.  
The results below synthesize the findings of 29 meta-analyses of prospective/cohort 
studies, 12 Mendelian randomization studies, and 2 meta-reviews, and 2 meta-analyses of 
RCTs. Individual details for the prospective meta-analyses and MR studies examining lifestyle 




Lifestyle factors in the prevention of mental disorders 
 
 
Physical activity and risk of depression 
 
A meta-analysis of 36 prospective comparisons29 found that higher levels of physical 
activity significantly reduced the subsequent risk of incident depression over a mean follow-
up time of 7.4 years (OR=0.837, 95% CI: 0.794-0.883), with low heterogeneity between 
included studies (I²=0%). Although there was indication of publication bias, adjusting for this 
did not alter overall findings (OR=0.85, 95% CI: 0.81-0.89). Subgroup analyses found similar 
results for protective effects of physical activity in studies measuring incidence of depressive 
symptoms (n=28, OR=0.844, 95% CI: 0.798-0.892) or major depressive disorder (n=10, 
OR=0.862, 95% CI: 0.757-0.981), and in children/adolescents (n=3, OR=0.907, 95% CI: 
0.836-0.985), adults (n=16, OR=0.787, 95% CI: 0.707-0.877) or older adults (n=16, 
OR=0.794, 95% CI: 0.726-0.868). Adjusting for baseline depressive symptoms, body mass 
index, smoking status, age, gender and other confounds did not alter the findings. 
Prospective associations between sedentary behavior and depression were examined in 
three meta-analyses30-32. The largest analysis examining overall sedentary behavior found 
that more sedentary individuals were at significantly increased risk of depression over time 
(determined via diagnostic records or clinical interviews) compared to less sedentary 
counterparts (n=11, RR=1.14, 95% CI: 1.06-1.21, I2=0%)32. However, subsequent meta-
analyses examining sedentary behavior specifically as “screen time” found no evidence that 
this domain significantly increased prospective risk of depressive symptoms in all available 
samples30, or in children and adolescents samples only31.  
Two MR studies examined the causal relations between physical activity and 
depression33,34. Choi et al34 applied a factor-wide design to Wray et al’s GWAS35, corrected 
for multiple testing and adjusted for potential confounders, to identify a broad spectrum of 
modifiable risk factors potentially implicated in major depression. MR analysis of the available 
variables related to physical activity found some evidence that self-reported cycling or 
swimming may causally decrease depression risk, although only at a nominal level of 
significance (which did not survive correction for multiple testing). Other self-report variables 
concerning specific types of physical activity (such as self-reported “part of a gym or club”, 
“walking for pleasure” or “heavy do-it-yourself, DIY”) had no evidence of causal relations with 
depression.  
A second study conducted a bi-directional two-sample MR to investigate risk of major 
depression in relation to both self-reported moderate-vigorous physical activity and objectively 




hours)33. Physical activity summary data were from Wray et al’s GWAS35. Initial analyses 
found no clear evidence that either form of activity causally influenced risk of major depression. 
However, as these initial analyses identified only two SNPs associated with overall objectively 
measured activity, a relaxed p value threshold of p<1x10-7 was used, which instead identified 
10 SNPs. Using this genetic instrument, there was strong evidence for objectively measured 
overall physical activity as a protective factor for major depression: IVW (inverse-variance 
weighted) OR=0.74, 95% CI: 0.59-0.92, p=0.006. This was consistent across multiple 
sensitivity analyses to test for pleiotropy. 
 
Physical activity and risk of anxiety and stress-related disorders 
 
The relationship between physical activity and incident anxiety was examined across 11 
cohorts with a total of 69,037 participants36. Over the average follow-up period of 3.5 years, 
higher levels of physical activity significantly reduced incident anxiety (OR=0.748, 95% CI: 
0.629-0.889), with low heterogeneity (I2=23.96%). There was some indication of publication 
bias, although significant positive effects of physical activity remained when adjusting for this 
(OR=0.86, 95% CI: 0.69-0.99). Examination of specific anxiety disorders indicated risk 
reduction from physical activity for agoraphobia (n=2, OR=0.43, 95% CI: 0.19-0.99) and post-
traumatic stress disorder (n=2, OR=0.58, 95% CI: 0.39-0.86), with no significant effects 
observed for other disorders. It should be noted, however, that only small samples were 
available for these subgroup analyses.  
A subsequent meta-analysis37 examining the longitudinal relations of physical activity with 
different measures of anxiety indicated protective benefits from high levels of physical activity 
for each measure, including elevated anxiety symptoms (n=9, OR=0.874, 95% CI: 0.77-0.99, 
I²=48.7%), anxiety disorder diagnosis (n=3, OR=0.663, 95% CI: 0.53-0.82, I²=62.3%), and 
generalized anxiety disorder (n=3, OR=0.544, 95% CI: 0.32-0.92, I²=0%), although limitations 
concerning the low number of studies and the considerable heterogeneity were again noted37. 
No MR studies examined the relationship between physical activity and the risk of anxiety.  
 
Physical activity and risk of psychotic and bipolar disorders  
 
One prospective meta-analysis examined prospective associations between physical 
activity for schizophrenia and related psychotic disorders38. Across five prospective 
comparisons, with 4-32 years of follow-up, higher levels of physical activity significantly 
reduced risk of incident psychosis (OR=0.728, 95% CI: 0.532-0.995, I²=36.9%). However, in 




psychosis incidence from physical activity were non-significant (OR=0.59, 95% CI: 0.253-
1.383, I²=54.7%).  
The risk of schizophrenia and bipolar disorder in relation to overall physical activity, 
moderate-intensity activity, and sedentary time was examined in one MR study39, using SNPs 
associated with device-measured physical activity over 72 hours from Stahl et al’s40 and 
Ruderfer et al’s41 GWAS. There was no strong evidence of causal relations with schizophrenia. 
However, the two-sample MR did find indication of causal relations between increased overall 
physical activity and decreased risk for bipolar disorder, equating to a 51% lower risk per 8 
milligravity increase in mean acceleration (IVW OR=0.491, 95% CI: 0.314-0.767, p=0.002). 
This estimate was consistent across multiple sensitivity analyses to test for pleiotropy. 
Associations with specific domains of sedentary behavior or moderate intensity activity were 
non-significant. 
 
Smoking and risk of common mental disorders 
 
Longitudinal associations between smoking exposure and subsequent risk of depression 
were examined in four meta-analyses of 19 studies with a total of 79,729 participants. Among 
52,568 adults, from seven studies with 1-6 year follow-ups, smoking significantly increased 
the prospective risk of depression, measured as either diagnosed depressive disorders or 
clinically-relevant depressive symptoms on validated scales (OR=1.62, 95% CI: 1.1-2.4, 
I2=N/R)42. 
A meta-analysis of six studies including 15,333 adolescents aged 13-19 showed that 
smokers were significantly more likely to develop depression than non-smokers over 1-6 year 
follow-up (OR=1.73, 95% CI: 1.32-2.4)43. There was notable heterogeneity among studies 
(I2=N/R, Q test p value=0.08).  
The impact of “second-hand smoking” in childhood on prospective risk of depression was 
examined across two cohort studies of 8,092 individuals44. Those exposed to second-hand 
smoking were at non-significantly higher risk of subsequent depressive symptoms (OR=1.51, 
95% CI: 0.93-2.09, I²=0%). Additionally, four prospective studies of 3,736 pregnant women 
found that prenatal smoking was associated with an almost three-fold increased risk of 
postpartum depression (OR=2.88, 95% CI: 0.99-8.39), although with high heterogeneity 
(I²=89.3%) and effects breaching the threshold for statistical significance (p=0.052)45.  
No meta-analyses examined the longitudinal relations between smoking and anxiety.  
Four MR studies examined smoking as a risk factor for depression or anxiety46-49. They 
assessed relations with individual SNPs located in the nicotine acetylcholine receptor gene 
cluster (rs16969968 or rs1051730 in CHRNA5-CHRNA3-CHRNB4 on chromosome 15), a 




is associated with smoking an additional cigarette each day (on average)50. Using this genetic 
instrument, analyses in the Norwegian HUNT study (N=53,601)46 and the Copenhagen 
General Population Study and City Heart Study (N=63,296)47 found no evidence for a causal 
association between smoking with primary depression or anxiety. No evidence for smoking 
increasing risk of antenatal depression was found in the Avon Longitudinal Study of Parents 
and Children (ALSPAC) cohort (N=6,294)48. A study of the Carta Consortium applied the same 
genetic instrument for smoking heaviness and found no causal effects on depression or 
anxiety (N=127,632)49.  
However, these studies lacked statistical power, due to the use of single genetic variants 
in the MR analyses. More recently, Wootton et al51 identified a genetic instrument for “lifetime 
smoking behavior”, consisting of 126 independent SNPs. This instrument captured smoking 
duration, heaviness and cessation in both smokers and non-smokers. The results provided 
evidence that lifetime smoking was causally associated with around a two-fold heightened risk 
of major depression (IVW OR=1.99, 95% CI: 1.71-2.32, p<0.001). Additionally, there was 
some, although weaker, evidence that genetic risk for major depression was causally 
associated with smoking (B=0.091, 95% CI: 0.027-0.155, p=0.005). Similarly, smoking 
initiation increased risk of major depression (IVW OR=1.54, 95% CI: 1.44-1.64, p<0.01), and 
major depression influenced smoking initiation (B=0.083, 95% CI: 0.039-0.127). The results 
were consistent across several more pleiotropy robust methods.  
 
Smoking and risk of psychotic disorders and bipolar disorder 
 
The prospective risk for incident psychotic disorders in those who engaged in regular 
tobacco use compared to non-smokers were calculated in two meta-analyses, both using data 
from over 1.7 million individuals52,53. These meta-analyses consistently found a significantly 
heightened prospective risk of psychotic disorders, of around two-fold for smokers vs. non-
smokers, in terms of daily tobacco use (n=6, RR=2.18, 95% CI: 1.23-3.85, I²=97.7%)53 and 
“personal active smoking” (n=6, RR=1.99, 95% CI: 1.1-3.61, I²=97%)52. However, significant 
publication bias was indicated and high levels of statistical heterogeneity were found52,53. 
Three MR studies investigated the causal influence of smoking on schizophrenia. First, 
the same SNP in the CHRNA3 gene cluster used in the above studies on depression 
(rs1051730) was used to examine effects on schizophrenia in a Danish general population 
sample and the international Psychiatric Genomics Consortium (PGC)47. Significant causal 
effects of smoking in increasing the risk of schizophrenia was found in the PGC (OR=1.60, 
95% CI: 0.74-3.47). Although the relationship between smoking and diagnosed schizophrenia 
in the Danish population fell short of statistical significance (OR=1.22, 95% CI: 0.84-1.79), this 




as further analyses examining smoking and odds of lifetime antipsychotic medication use in 
this sample (N=2,795 cases) found evidence for a significant causal relationship (OR=1.16, 
95% CI: 1.02-1.31).  
Second, a two-sample MR analysis55 used a genetic instrument for “smoking initiation” 
(i.e., ever having smoked, without taking into account heaviness, duration or cessation) 
identified in the Tobacco and Genetics Consortium, and used it to predict schizophrenia in the 
PGC. They found no consistent evidence for causal relations between initiation of smoking 
and schizophrenia diagnosis, in either direction.  
Third, the same genetic instrument used for lifetime smoking (capturing lifetime duration, 
heaviness and cessation of smoking) in the aforementioned MR study of smoking and 
depression51 found that lifetime smoking significantly increased the risk for schizophrenia 
(OR=2.27, 95% CI: 1.67-3.08, p<0.001). There was also an indication of schizophrenia 
increasing lifetime smoking (B=0.022, 95% CI: 0.005-0.038, p=0.009). 
This MR study51 also updated the earlier two-sample MR analysis of smoking initiation55, 
using the more recent GSCAN GWAS instrument (comprising 378 genome-wide significant 
independent SNPs), and found evidence for an effect of smoking initiation on risk of 
schizophrenia (IVW OR=1.53, 95% CI: 1.35-1.74, p<0.001), but less clear evidence for an 
effect of schizophrenia on smoking initiation (B=0.010, 95% CI: 0.000-0.021, p=0.04). The 
effects of smoking on schizophrenia were consistent across multiple sensitivity methods more 
robust to pleiotropy.  
Concerning the relationship between smoking and bipolar disorder, no prospective meta-
analysis examined relative odds in smokers vs. non-smokers. However, a two-sample MR 
study56 assessed the impact of both smoking initiation and total lifetime smoking (using the 
same genetic instruments as those described above51) on risk of bipolar disorder across 
41,653 individuals from the PGC (including 20,129 cases and 21,524 controls), using 
summary level data. These analyses found evidence suggesting that smoking was a causal 
risk factor for bipolar disorder (IVW OR=1.46 for smoking initiation, 95% CI: 1.28-1.66, 
p<0.001, and IVW OR=1.72 for lifetime smoking, 95% CI: 1.29-2.28, p<0.001), consistently 
across pleiotropy robust sensitivity methods. On the other hand, there was no clear evidence 
that the diagnosis of bipolar disorder causally affected the risk of smoking-related outcomes56.   
 
Smoking and risk of ADHD 
 
The link between smoking and the incidence of ADHD was examined in one meta-
analysis57 and one MR analysis58. 
A large-scale meta-analysis of 15 cohort studies including 2,965,933 individuals 




mothers57. Pooled analyses of ORs adjusted for a range of confounding maternal factors (e.g., 
mother’s age, education and socio-demographic status) and offspring variables (i.e., child’s 
gender and gestational age) showed that maternal smoking significantly heightened the risk 
of ADHD (OR=1.35, 95% CI: 1.2-1.52, I²=59.5%). There was non-significant indication of 
publication bias, and results were robust even when adjusting for this. 
The MR study applied a two-sample MR approach using the most recent GWAS of 
smoking initiation58 from the GSCAN consortium and ADHD diagnoses after age 18 years59. 
Bi-directional analyses found that smoking initiation significantly increased risk of ADHD 
(OR=3.72, p<0.001), while ADHD also affected smoking initiation (B=0.07, p<0.001). 
However, smoking initiation also predicted ADHD diagnosis before age 13 years, leading the 
authors to conclude that results could be due to pleiotropy. 
 
Diet and risk of depression 
 
The association between dietary patterns and longitudinal risk for depression (defined as 
clinical depression or depressive symptoms) was examined in ten eligible meta-analyses.  
A meta-analysis pooling all “healthy dietary patterns” from 17 comparisons (total 
N=127,973) found that these patterns were associated with significantly reduced prospective 
risk of depression (OR=0.77, 95% CI: 0.69-0.84, I²=88.3%)60. Similar effects were observed 
in a pooled analysis of “healthy food groups” such as fish, vegetables and fruits (n=18, 
N=147,011, OR=0.89, 95% CI: 0.83-0.95, I²=71.3%)60. However, pooled analyses for all 
“unhealthy dietary patterns”, “unhealthy food groups” and “neutral food groups” found that 
none of these categories were significantly associated with the risk of depression60. 
In a more recent meta-analysis examining specific whole-of-diet patterns, the risk of 
depression was decreased for those with a high Mediterranean diet score (n=5, N=36,556, 
OR=0.67, 95% CI: 0.55-0.82, I²=33.1%) with low heterogeneity between studies. Prospective 
associations with the DASH diet score (OR=0.89, 95% CI: 0.6-1.31, I²=68.0%) and Healthy 
Eating Index/Alternative Healthy Eating Index (AHEI) scores (OR=0.76, 95% CI: 0.57-1.02, 
I²=80.7%) had greater heterogeneity and were non-significant61. The Mediterranean diet score 
is typically based on nine items: five regarded as beneficial (fruit, vegetables, legumes, 
cereals, fish), two as detrimental (meat, dairy), one component on fat, and one on moderate 
alcohol intake. The DASH (dietary approaches to stop hypertension) diet score considers eight 
components (negative: sweet beverages, meat, sodium; positive: fruit, vegetables, legumes 
and nuts, wholegrain, low-fat dairy). The AHEI includes 11 components (vegetables, fruit, nut 
and soy protein, ratio of white to red meat, cereal fiber, trans fat, polyunsaturated-to-saturated 




A subsequent but smaller meta-analysis of three harmonized datasets, and controlling for 
depressive symptoms at baseline, found significantly reduced risk of depressive symptoms 
among those with high Mediterranean diet score (OR=0.88, 95% CI: 0.80-0.96, I²=15.4%) or 
DASH score (OR=0.90, 95% CI: 0.84-0.97, I²=0%) with little or zero heterogeneity62. 
Prospective associations with the AHEI were non-significant62.  
A lower Dietary Inflammatory Index (an index that quantifies the inflammatory potential of 
a diet based on up to 45 food parameters) was also found to be associated with reduced risk 
of depression (n=7, N=32,908, OR=0.76, 95% CI: 0.63-0.92, I²=55.3%)61. Confirming this, a 
separate meta-analysis examining the opposite direction of effect found that individuals with 
pro-inflammatory diets at baseline were at significantly greater risk of depression, with low 
heterogeneity between studies (n=10, N=77,420, OR=1.31, 95% CI: 1.2-1.44, I²=5.1%), with 
equally large risk observed in studies using >10 year or <10 year follow-up periods63.  
Of note, however, the results of the above meta-analyses were based mostly on self-
reported of depressive symptoms. Small subgroup analyses of studies which used clinical 
diagnoses of depression as the outcome did not find significant associations with dietary 
patterns60. 
Eligible data on various individual dietary aspects were presented in seven meta-
analyses. Prospective risk of depression (including self-reported depressive symptoms) was 
significantly lower for those with greater intakes of vegetables (n=7, RR=0.86, 95% CI: 0.75-
0.98, I²=68.1%)64, dietary zinc (n=3, RR=0.73, 95% CI: 0.6-0.9, I²=0%)66, fish (n=16, 0.86, 95% 
C.I: 0.78-0.95, I²=68.4%)60, and dietary eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA) (n=4, RR=0.74, 95% CI: 0.61-0.89, I²=0)65, while associations with dietary omega-
3 fatty acids also approached significance (n=7, RR=0.85, 95% CI: 0.73-1.00, I²=19%)65. 
The prospective risk of depression was significantly higher for those with greater 
consumption of sugar-sweetened beverages (n=4, RR=1.30, 95% CI:1.19-1.41, I²=0%)68.  
Although greater fruit intake was prospectively associated with reduced risk (n=6, RR=0.83, 
95% CI: 0.71-0.98, I²=84.5%)64 and meat consumption was associated with heightened risk 
(n=3, RR=1.13, 95% CI: 1.03-1.24, I²=19.4%)67 for depression in meta-analyses focusing 
specifically on these foods, subgroup analyses within a broader meta-analysis found no 
significant associations for depression with either fruit intake or meat intake60.   
No significant prospective associations with depression were found for dietary glycaemic 
index (n=2, HR=1.05, 95% CI: 0.76-1.44, I²=86.1%)69, legumes/pulses (n=4, OR=0.93, 95% 
C.I: 0.79-1.10, I²= 43.1%)60, or nuts/seeds/soy (n=2, OR=0.92, 95% C.I: 0.84-1.02, I²= 0.1%)60. 
It should also be noted that the strength of the findings for individual dietary aspects is reduced 
by the high levels of heterogeneity, limited comparisons within the meta-analyses, lack of 
clinical diagnostic outcomes used, and inadequate control for how the individual dietary 




The only MR study to examine causal relations between diet and incident mental illness 
was the aforementioned analysis of data from Wray et al’s GWAS34, which also examined 
multiple dietary factors, including salt intake, lamb intake, inconsistent dietary patterns, 
multivitamin supplement use, tea intake, and cereal intake. There was no firm evidence that 
any of these factors influenced the risk of developing depression, apart from an unexpected 
effect of multivitamin supplementation use on increased risk (OR=1.28, 95% CI: 1.11-1.47, 
p=0.0006), which however was not consistent across sensitivity methods.  
No prospective meta-analyses or MR studies examined the relationships between dietary 
nutrient intake and the risk for mental disorders other than depression. 
 
Sleeping patterns and risk of mental disorders 
 
A meta-analysis pooling all “sleep disturbances” (including insomnia, complaints of 
sleeping difficulties, and general poor sleep quality) found that they significantly increased the 
prospective risk for clinical depression or significant depressive symptoms (n=11, N=16,108, 
RR=1.92, 95% CI: 1.60-2.30, I2=10.2%), with even greater risk following “persistent” sleep 
disturbances (n=4, N=3,602, RR=3.90, 95% CI: 2.77-5.48, I2=27.1%)70. There was little 
heterogeneity between studies.  
Beyond generalized sleep disturbances, a large prospective meta-analysis of data from 
172,007 individuals in 34 examinations of “insomnia” (primarily identified from night-time 
symptoms) found that it significantly increased the risk for future depression (RR=2.27, 95% 
CI: 1.89-2.71, I2=92.6%)72. However, there was high heterogeneity and many studies were of 
short (<12 months) duration. Nonetheless, a subsequent meta-analysis examining the 
psychiatric outcomes of insomnia from studies with at least 12 months follow-up similarly 
found heightened risk in pooled analysis for all psychiatric disorders (n=19, N=133,967, 
OR=2.60, 95% CI: 1.70-3.97, I2=96.2%), along with statistically significant relations in all 
individual conditions examined, including for depression (n=10, OR=2.83, 95% CI: 1.55-5.17, 
I²=93.67%), anxiety (n=6, OR=3.23, 95% CI: 1.52-6.85, I²=96.37%) and psychotic disorders 
(n=1 only, data not shown)73. 
Concerning sleep duration, individuals with both short (median reference value: ≤6 hours) 
and long (median reference value: ≥8 hours) average daily sleep duration were at significantly 
higher risk of depression over the 7.9 year average follow-up, with no heterogeneity between 
studies (short sleep: n=7, N=25,271, RR=1.31, 95% CI. 1.04-1.64; long sleep: n=5, N=23,663, 
RR=1.42, 95% CI: 1.04-1.92)74. A separate meta-analysis also indicated that short sleep 
duration increased the prospective risk of ADHD (n=3, N=2,386, RR=2.61, 95% CI: 1.36-5.00, 
I2=83.0%)75, although the low number of studies and the lack of control for baseline ADHD 




Three MR studies assessed the causal role of sleep-related variables on risk for mental 
illness. Two of these were from the aforementioned two-sample MR studies of physical 
activity, which also measured sleep time using self-reported34 and objective39 measures. 
There was no evidence for causal associations between hours of sleep with depression, 
schizophrenia or bipolar disorder. However, it must be noted that MR can only test linear 
effects, whereas prospective meta-analyses indicate non-linear relations between sleep 
duration and mental illness74.  
For disordered sleeping, a two-sample MR study found evidence that self-reported 
difficulties in falling or staying asleep increase the risk for bipolar disorder (OR=1.79, 95% CI: 
1.40-2.29, p<0.001), an effect which was consistent across multiple sensitivity methods to test 
for pleiotropy, whereas no evidence was found for depression, ADHD or schizophrenia76. 
However, the study by Choi et al34 did find evidence for self-reported inadvertent daytime 
napping as a risk factor for the onset of depression (OR=1.34, 95% CI: 1.17-1.53, p=0.00002), 
consistent across pleiotropy robust sensitivity methods.  
 
Lifestyle interventions in the treatment of mental disorders 
 
Efficacy of physical activity interventions for mental disorders 
 
One recent meta-review provided sufficient information on the efficacy of physical activity 
for the treatment of eligible psychiatric conditions, bringing together the data from 16 meta-
analyses of RCTs77. The most widely assessed condition was major depression, with four 
meta-analyses in adult samples finding significant positive effects of exercise interventions in 
comparison to various control conditions, including waitlist and usual treatment, control 
interventions of flexibility, stretching/relaxation and meditation, and placebo medications.  
The largest and most recent was a meta-analysis showing moderately large benefits of 
exercise across 35 RCTs in adults with depressive disorders (SMD=–0.66, 95% CI: –0.86 to 
–0.46, I²=81%). However, only small, non-significant benefits were observed in four trials 
deemed of “high quality” and comparing exercise to other active control conditions (SMD=–
0.11, 95% CI: –0.41 to 0.18, I²=62%).  
Within the meta-review, two meta-analyses of RCTs examined exercise in youth with 
depressive disorders, and both found significant effects. The most recent observed a large, 
positive benefit of exercise compared to both waitlist and attention-matched control conditions 
(n=4, N=100, SMD=–0.95, 95% CI: –1.37 to –0.53, p<0.001, I²=0%). Only two trials examined 
the impact of exercise in older people with a diagnosis of major depressive disorder and did 
not find a significant effect (SMD=–1.883, 95% CI: –4.21 to 0.44, p=0.11, I²=93%), although 




symptoms (n=8, N=267, SMD=–0.90, 95% CI: –1.51 to –0.29, p=0.004). The cognitive 
benefits of exercise in major depression were examined in eight trials, showing no overall 
benefits. 
Concerning the treatment of anxiety and stress-related disorders, the most recent meta-
analyses found exercise reduced symptoms significantly more than control conditions in 
pooled analyses of RCTs in patients with panic disorder, generalized anxiety disorder, post-
traumatic stress disorder and social phobia (n=6, N=262, SMD=–0.581, 95% CI: –1.09 to –
0.076, I²=66%) and in people receiving treatment for anxiety in primary care (n=4, SMD=–
0.32, 95% CI: –0.62 to –0.01). However, an earlier meta-analysis found inconsistent evidence 
for significant benefits, with the effects of exercise on anxiety disorders varying with regards 
to the type of control condition used77. 
In schizophrenia and non-affective psychotic disorders, physical activity interventions 
across 8 RCTs did not significantly reduce total symptoms. However, RCTs of exercise 
interventions which used at least 90 min of moderate to vigorous activity per week did 
significantly reduce total symptoms (SMD=–0.72, 95% CI: –1.14 to –0.29), positive symptoms 
(SMD=–0.54, 95% CI: –0.95 to –0.13) and negative symptoms (SMD=–0.44, 95% CI: –0.78 
to –0.09) more than control conditions77. Exercise was also found to significantly improve 
global cognition in schizophrenia (n=7, SMD=0.412, 95% CI: 0.19 to 0.64). Earlier meta-
analyses examining the effects of aerobic exercise on comorbid symptoms of depression and 
anxiety in schizophrenia populations found no significant effects.  
The effects of exercise in bipolar disorder were not investigated in any meta-analyses of 
RCTs. A meta-analysis of RCTs in children with ADHD found moderately large, statistically 
significant effects of aerobic exercise for various outcomes, including attention, hyperactivity, 




Efficacy of smoking cessation interventions for mental disorders 
 
The impact of non-pharmacological smoking interventions on psychiatric symptoms in 
populations with mental disorders was not reported in any meta-analyses of RCTs. 
 
Efficacy of dietary interventions for mental disorders 
 
One eligible meta-review examined dietary interventions in the treatment of a mental 
disorder, specifically the effects of food exclusion diets in children with ADHD78. Four relevant 




removing all foods from the diet which contain AFCs), and two on “few-foods diets” (i.e., 
eliminating many potentially symptom-triggering foods, to include only a limited selection of 
natural foods in the diet).  
The results from meta-analyses of placebo-controlled trials indicated a non-significant 
trend towards improvement in symptoms of ADHD from AFC elimination across parent-rated 
measures (n=11, SMD=0.21, 95% CI: –0.02 to 0.43, I²=68%, p=0.07), with no effects for 
teacher-rated measures (n=6, SMD=0.08, 95% CI: –0.07 to 0.24, I²=0%) and observed-rated 
measures (n=4, SMD=0.11, 95% CI: –0.13 to 0.34, I²=12%)78.  
The few-foods diets were found to have significant positive effects on ADHD symptoms. 
The recalculated meta-analyses found moderately large effect sizes in RCTs of the few-foods 
diets for any-rater measures (n=5, SMD=0.75, 95% CI: 0.31-1.19, I²=58.6%) and parent/ward 
observation measures (n=5, SMD=0.78, 95% CI: 0.42-1.14, I²=48.5%) of ADHD symptoms78. 
The few-food diets were broadly described as “lamb, chicken, potatoes, rice, banana, apple 
and brassica”, although noting that this could be customized to child/parent preference while 
maintaining the core “few-foods” concept of avoiding artificially sweetened and highly refined 
foods which could provoke symptomatic response.  
No meta-analyses of dietary interventions in the treatment of other mental disorders were 
identified.  
 
Efficacy of sleep interventions for mental disorders 
 
The efficacy of sleep interventions in the treatment of psychiatric conditions was 
investigated in two independent meta-analyses. In a pooled analysis of seven RCTs across a 
mixed psychiatric sample with anxiety, depression or PTSD, non-pharmacological sleep 
interventions – predominantly based on cognitive behavior therapy (CBT) – produced a large 
and significant reduction in depressive symptoms in comparison to control conditions (NIH=6, 
SMD=0.81, 95% CI: 0.49-1.13, I2=27%)79. While heterogeneity was low, there was some 
indication of publication bias, with larger effects observed in smaller studies in the meta-
analysis79. Large, significant reductions in depressive symptoms were also found from 
continuous positive airway pressure in people with depression and comorbid obstructive sleep 
apnoea (NIH=6, SMD=2.00, 95% CI: 1.39-2.62, I²=12%)80, but included data from only two 











This meta-review provides a systematic and comprehensive appraisal of the current 
evidence concerning the role of the key modifiable “lifestyle factors” of physical activity, 
smoking, diet and sleep in the prevention and treatment of mental disorders.  
From the literature to date, physical activity emerges as the most widely researched 
lifestyle factor. There is substantial evidence from multiple meta-analyses of longitudinal data 
and MR studies that physical activity has a protective role in reducing risk for common mental 
disorders. Furthermore, while further replication in high-quality RCTs is needed, meta-
analyses of RCTs have found exercise interventions may provide effective adjunctive 
treatment for depression, anxiety and stress-related disorders, psychotic disorders and ADHD.  
In public health guidelines, 150 min of moderate activity or 75 min of vigorous activity per 
week (or some combination of these) are recommended for reducing risk of various health 
conditions in adults13,14. However, it is important to keep in mind that, unlike chronic physical 
diseases, most mental disorders first arise in young people6,82. Simply advising young people 
to be more active is unlikely to have a substantial impact on behavior change. Instead, 
realizing the protective role of physical activity will likely require systemic integration of the 
evidence presented here within environmental modification alongside mental and physical 
health promotion initiatives for young people83, which can be feasibly delivered through school 
settings84 and as part of cross-sectoral public health strategies. For treatment of diagnosed 
mental illness, supervised exercise interventions are recommended, incorporating moderate-
to-vigorous activity, and delivered by trained exercise professionals either working within 
mental health services or made available through referral to community-based schemes9,17. 
Current recommendations pertain largely to aerobic activity and cardiorespiratory fitness 
as the focus of exercise interventions, as the majority of observational and interventional 
research in this area has focused on overall physical activity levels. While this is well-
supported by the literature (with growing evidence of cardiorespiratory fitness itself reducing 
risk of psychiatric disorders85-87), it should also be noted that there is now some evidence that 
muscular strength and resistance training also are protective against mental illness, even 
independently of general physical activity88-90. Furthermore, strength training interventions can 
significantly improve mental health91,92, with effects that may persist over and above those of 
aerobic exercise alone93. Thus, future research and guidelines on physical activity should 
afford further consideration to the efficacy and feasibility of resistance training interventions, 
in both the prevention and treatment of mental illness.  
There is a significant body of evidence that poor sleep is another key modifiable lifestyle 
factor, with large-scale meta-analyses of showing prospective links with various psychiatric 




disorder. Alongside this, sleep disturbances have been found to significantly heighten the risk 
of suicidal behaviour in people living with mental illness71. 
Furthermore, meta-analyses of RCTs also support the efficacy of sleep interventions in 
reducing symptoms of depression. Of note, whereas many trials have shown the alleviation of 
subclinical depressive symptoms following sleep interventions, the available evidence 
suggests that even larger effects of sleep therapies on depression are observed in those with 
mental illness79-81,94. Additionally, a role of poor sleep in severe mental disorders is suggested 
by a recent RCT showing that cognitive behavioral therapy for insomnia (CBT-I) significantly 
reduces the severity of hallucinations and paranoia in youth experiencing symptoms of 
psychosis95.  
Overall, poor sleep appears to play an important part in the onset and aggravation of 
mental illness, and CBT-I may provide an attractive non-pharmacological option (which can 
also be delivered digitally) for improving sleep and other aspects of mental health94-96. 
Establishing the feasibility and effectiveness of CBT-I in people with psychotic disorders is a 
priority for future research.  
The evidence that tobacco use is a significant and modifiable risk factor for a range of 
psychiatric conditions is becoming increasingly strong. Whereas early MR studies found 
inconsistent effects, the most recent GWAS studies have improved statistical power to provide 
strong indications for smoking as a causal factor in the onset of major depression, bipolar 
disorder and schizophrenia. These findings are in line with multiple meta-analyses showing 
that smoking is associated with a heightened prospective risk of mental disorders, earlier age 
of onset, and adverse outcomes in those living with mental illness53,54.  
Collectively, these findings provide additional evidence for public health bodies to justify 
tobacco control initiatives which can effectively reach vulnerable, deprived or marginalized 
groups. In fact, people with mental illness have so far not clearly benefitted from the recent 
reductions in tobacco smoking rates observed in the general population across Western 
societies97.  
Although we did not identify any meta-analyses of RCTs for smoking cessation reducing 
symptoms of psychiatric disorders, a consistent body of work shows that stopping smoking 
does not cause deterioration in mental health among those with mental illness (an assumption 
which can sometimes be a barrier towards implementation in clinical settings)98, and in fact 
appears to improve psychological well-being99, including in those living with mental illness. 
Furthermore, the critical need for such interventions in mental health care settings is already 
acknowledged on the basis of physical health risks – as smoking is a leading cause of the 15 
to 30 year premature mortality associated with severe mental illness100. Lastly, the role of 
tobacco use as a cause of psychiatric disorders, and source of health inequalities, warrants 




The causal effects of diet on common and severe mental illnesses are less clear. Several 
meta-analyses have shown that healthy dietary patterns are associated with a significantly 
reduced risk of depressive symptoms. However, prospective links with diagnosed depression 
or other mental disorders were not established. There was also an absence of MR evidence 
to support causal roles of dietary patterns in the onset of any mental illness. 
Furthermore, a recent four-arm RCT examined nutrition-based interventions for the 
prevention of depressive episodes in 1,025 participants with subclinical depressive symptoms, 
and found no significant benefits from the behavioral activation intervention promoting healthy 
eating101. However, the null effects may be due to poor intervention adherence, given the very 
marginal improvements in diet quality reported. Interestingly, the other “active” arm of this RCT 
provided daily multinutrient supplementation, observing significantly worsened outcomes for 
depressive symptoms compared to placebo101. Although seemingly paradoxical, these 
counterintuitive findings align with results from the MR study by Choi et al34, in which the only 
dietary nutrition factor with evidence for causal relations was multivitamin supplement use 
relating to increased depression risk.  
Clearly, further research is needed to establish how nutrition impacts on mental health. 
Nonetheless, for those living with current mental illness, a number of existing clinical trials 
have already suggested that dietary interventions may be used alongside standard care to 
improve outcomes. Along with the preliminary evidence for specific dietary interventions in 
ADHD presented above, several recent RCTs (not captured in our meta-review) have reported 
significant improvements in clinical depression from Mediterranean diet interventions, 
observing moderately large positive effects102-104. While further replication of these findings is 
still required to determine effects on mental health, the high levels of dietary risk factors and 
associated cardiometabolic diseases associated with mental illness6,105 already provides a 
basis for considering dietary factors within multidisciplinary healthcare for people with mental 
illness106.  
Further research is also required to explore the neurobiological pathways through which 
various lifestyle factors impact mental health, as mechanistic evidence from intervention trials 
is currently sparse. One potentially shared biological mechanism by which multiple adverse 
health behaviors could increase risk of mental illness is through inflammation, which has been 
linked with a broad range of psychiatric disorders112. As previous research has indicated anti-
inflammatory effects from exercise113, Mediterranean diet114, improved sleep115 and smoking 
cessation116, this may partially explain the effects of lifestyle interventions on improving mental 
health.  
Further mechanistic insights are available from studies inducing an adverse health 
behavior in otherwise healthy samples, and then observing the potentially detrimental effects 




“unhealthy” meals (e.g., high in glycaemic index or saturated fats) can increase depressive 
symptoms and inflammatory markers in healthy human subjects69,108,109. Whereas less direct 
experimental evidence exists for smoking or poor sleep, both of these factors have also been 
shown to have pro-inflammatory effects in humans110,111. However, a recent systematic review 
of induced exercise cessation in previously active adults found that although exercise 
cessation did significantly increase in depressive symptoms within 2 weeks, this was not 
accompanied by increases in inflammatory markers107, suggesting other mechanisms must 
explain these effects. 
The role of the gut microbiome in mental health is currently receiving considerable 
research interest117. Since the microbiome appears to be influenced by exercise118 and diet119, 
this could be considered as another potential pathway through which modifiable health 
behaviors could impact on mental health. However, scientific understanding in this area is still 
in its infancy, and even the nature of a “healthy microbiome” has yet to be established120. 
Therefore, triangulating the causal relations between lifestyle, mental health and the gut 
microbiome is currently speculative, although represents an intriguing avenue for future 
rigorous research.  
Besides these possible direct mechanisms, it is also important to consider how the 
downstream consequences of adverse health behaviors may link lifestyle factors to mental 
disorders. For instance, insufficient exercise, poor diet, and even sleep disturbances can be 
contributing factors towards the development of metabolic diseases and obesity, which 
themselves may adversely impact mental health121-123, and have been linked to the recent rise 
of mental illness in young people7.  
The biological, social and psychological pathways through which physical health 
conditions such as obesity, diabetes and even cardiovascular diseases affect mental health 
have yet to be fully determined. Nonetheless, the emerging field of “lifestyle psychiatry” must 
not neglect the body of evidence around previously established health-related and social 
determinants of psychological well-being, and their interaction with lifestyle factors6,9, in the 
development of prevention and treatment initiatives for mental illness.   
Additionally, as the field moves forward, further consideration of the role of “newer” 
lifestyle factors is warranted. Specifically, the widespread use of digital technologies is gaining 
increasing attention from the public, researchers and clinicians with regards to potential 
influence on psychological well-being. A growing body of research has identified multiple 
pathways through which constant Internet usage may be affecting our cognitive and social 
processes, along with mental health and brain functioning124. On the other hand, there is also 
a rapidly growing body of research examining the potential for using digital technologies in the 
prevention and treatment of mental illness. Recent meta-analyses of RCTs have shown that 




can be delivered remotely via smartphone apps125, with a smaller but emerging evidence base 
also for psychotic disorders126.  
Despite these recent increases in the amount of empirical research on the interaction 
between digital technologies and mental health, there is still a need for further large-scale and 
interventional research to determine what types and quantities of usage impact on mental 
health, and how this interacts with other lifestyle factors, such as sedentary behavior and diet.  
In conclusion, health behaviours may play an important role in prevention and treatment 
of mental illness. The converging lines of supportive evidence for the roles exercise, smoking, 
diet and sleep are summarized in Figure 1 (with further details on quality and consistency of 
evidence displayed in Tables 1-8). At the public health level, further research is still required 
to improve evidence-based implementation of health promotion initiatives, and to determine 
their impact on risk of mental illness. Nonetheless, the positive mental health findings from 
system-wide approaches to health promotion in children and adolescents83,84 reinforces the 
assertion that effectively addressing multiple lifestyle factors in young people presents a 
promising approach towards tackling the rates of mental illness across the population6,7,83,84.  
For clinical settings, the findings presented above add to the growing rationale for broad-
scale provision of lifestyle interventions within primary and secondary care services for people 
with mental disorders6,9,17,18. These should aim to capture all “core principles” of evidence-
based lifestyle interventions for mental illness, which briefly can be summarized as: a) using 
behavior change techniques with specific, measurable behavioral goals and self‐monitoring; 
b) involving  dedicated “physical health” staff, such as professionals in specific aspects of 
health behavior change, delivering supervised sessions for service users; c) training mental 
health staff in the importance and goals of lifestyle interventions; and d) facilitating peer‐
support to improve uptake and adherence9.  
Further research is required to address the existing barriers towards implementation and 
dissemination of lifestyle interventions. For instance, harnessing the reach of digital 
technologies may present a new option for wide-scale delivery of lifestyle-based prevention 
and management strategies for mental illness, which may be particularly useful for low- and 
middle-income settings, where traditional mental health care services are often unavailable. 
However, further investigation into how certain aspects of digital technologies may pose a new 
“lifestyle risk factor” for mental health is also required.  
Finally, as the field progresses, it must always be considered that the etiology of mental 
disorders is of course multifactorial, and cases will often occur (and persist) independently of 
lifestyle factors. Thus, attributing an individual’s condition to his/her health behaviors would 
often be ill-founded, stigmatizing and unhelpful. Instead, the onus to act is on policy makers, 
public health bodies, and clinical services to properly address adverse health environments 
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Table 1  Physical activity and prospective risk of mental disorders in meta 
analyses 
 
 Outcome n Exposure Main results Summary 
Schuch et al29 







OR=0.837, 95% CI: 0.794-0.883 
I²=0.00% 
Good quality review indicating that high levels of physical activity reduce the risk of 
depression. Effects persisted across age groups and geographic regions. Although there 
was evidence of significant publication bias, correcting for this did not alter the indicated 
protective effects. 
Wang et al30 








OR=1.02, 95% CI: 1.01-1.04 
I²=3.0% 
Fair quality review which concluded screen time-based sedentary behavior did not 
significantly increase the prospective risk of depression, with low heterogeneity. 
Liu et al31  




Screen time in 
children and 
adolescents 
OR=0.88, 95% CI: 0.67-1.14  
I²=90.4% 
Fair quality review finding no prospective associations between screen time and depression. 
However, there was a lack of large-scale longitudinal studies to determine this.  
Zhai et al32 







RR=1.14, 95% CI: 1.06-1.21 
I²=0.00% 
Fair quality review showing that higher sedentary behaviour (of all types) at baseline was 
associated with increased risk of depression at follow-up.  
Schuch et al36 
(NIH = 7) 
Incident anxiety  11 
Higher physical 
activity levels 
OR=0.748, 95% CI: 0.629-0.889 
I²=23.96% 
Good quality review indicating that self‐reported physical activity reduces the risk of anxiety. 
There was evidence of significant publication bias, and correcting for this slightly reduced the 
protective effects. Subgroup analyses found that physical activity reduces risk of 
agoraphobia and post-traumatic stress. 
McDowell et 
al37 
(NIH = 7) 
Anxiety symptoms 9 
Higher physical 
activity levels 
OR=0.874, 95% CI: 0.77-0.99 
I²=48.7% 
Good quality review showing that physical activity is associated with reduced risk of anxiety 
symptoms and anxiety disorders. The moderate degree of heterogeneity between studies 
and the limited number of studies using diagnosis outcomes prevents firm conclusions. 
 Any anxiety disorder  3 
OR=0.663, 95% CI: 0.53-0.82 
I²=62.3% 
Diagnosed GAD 3 




Psychotic disorders 5 
Higher physical 
activity levels 
OR=0.728, 95% CI: 0.532-0.995  
I²=36.9% 
Fair quality review showing that higher levels of physical activity are associated with 






n – number of comparisons, OR – odds ratio, RR – risk ratio, NIH – quality of the study evaluated by the National Institutes of Health’s Quality Assessment Tool for Systematic Reviews and Meta-Analyses (good: 7 or 8; 




(NIH = 6) not observed in the two studies that sufficiently adjusted for confounding factors, although 




Table 2  Causal relations of physical activity and mental disorders in Mendelian randomization studies  
 Outcome Sample Exposure Main results Summary 
      
Choi et al33 
Major 
depression 
N=143,265 from  
Wray et al’s GWAS35 
Self-reported moderate-
vigorous physical activity 
(9 SNPs) 
Objective accelerometer 
activity (10 SNPs) 
Self-reported: IVW OR=1.28, 95% CI: 0.57-3.37, 
p=0.48 
Objective: IVW OR=0.74, 95% CI: 0.59-0.92, 
p=0.006 
This bi-directional analysis found evidence that 
accelerometer-measured physical activity was 
protective for depression. Evidence was consistent 
across multiple pleiotropy robust methods. There 
was no clear evidence to suggest that depression 
risk decreased physical activity. Equally, there was 
no clear evidence that self-reported physical 
activity was protective for major depression. The 
analysis was run with a relaxed p value threshold 
of p<1x10-7. 
 Choi et al34 
Major 
depression 
N=431,394  from  
Wray et al’s GWAS35 
Self-reported: 
part of a gym/club; 
usual walking pace; 
walking for pleasure; 
transport by walking; 
frequency of walking; 
heavy do-it-yourself 
(DIY); 
other exercise (including 
swimming and cycling) 
Gym/club member: IVW OR=0.91, 95% CI: 0.784-
1.057, p=0.217 
Walking pace: IVW OR=1.038, 95% CI: 0.877-
1.228, p=0.666 
Walking for pleasure: IVW OR=1.02, 95% CI: 
0.918-1.123, p=0.765 
Transport by walking: IVW OR=0.983, 95% CI: 
0.870-1.111, p=0.782 
Frequency of walking:  IVW OR=1.024, 95% CI: 
0.849-1.234, p=0.807 
DIY:  IVW OR=0.995, 95% CI: 0.889-1.114, 
p=0.931  
Other:  IVW OR=0.90, 95% CI: 0.82-0.99, p=0.033 
There was no clear evidence for any of the 
examined factors being causal. There was a 
nominal association with other exercise (e.g., 
swimming and cycling), but this did not survive 
Bonferroni correction. When testing the effects of 
depression on these outcomes, none was 
significant after Bonferroni adjustment. 
Sun et al39 Bipolar disorder 
N=20,352 cases and 
31,358 controls from 
Stahl et al’s GWAS40 
Device measured: 
overall activity  
(5 SNPs); 
Overall activity:  IVW OR=0.491, 95% CI: 0.314-
0.767, p=0.002.  
Sedentary time:  IVW OR=0.702, 95% CI: 0.366-
1.345, p=0.287 
Moderate activity:  IVW OR=0.726, 95% CI: 0.255-
2.068, p=0.549 
Overall physical activity was protective for bipolar 
disorder and this result was consistent across the 
more pleiotropy robust methods. No evidence was 












GWAS – genome-wide association study, SNP – single nucleotide polymorphism, IVW OR – inverse-variance weighted odds ratio 
  
Schizophrenia 
N=33,426 cases and 
32,541 controls from 






Overall activity:  IVW OR=1.133, 95% CI: 0.636-
2.020, p=0.672 
Sedentary time:  IVW OR=0.707, 95% CI: 0.430-
1.161, p=0.170  
Moderate activity:  IVW OR=0.657, 95% CI: 0.378-
2.026, p=0.379 
disorder risk did not influence physical activity). 
There was no evidence for an effect of overall 
activity on schizophrenia, nor evidence that 
sedentary behavior or moderate intensity activity 



















































Table 3  Smoking and prospective risk of mental disorders in meta-analyses  
 Outcome n Exposure Main results Summary 
Luger et al42 







Smokers vs. never smokers 
OR=1.62, 95% CI: 1.1-2.4, 
I²=NA 
Smoking was strongly associated with risk of depression, with 
effects of 1.5-2 times the risk of non-smoking from a variety of 
designs, measurements and populations. However, review 
quality scored low, and the impact of publication bias and study 
heterogeneity was not determined.  
Chaiton et al43 
(NIH = 4) 
Adolescent 
depression 
(diagnosis or clinical 
symptoms) 
6  Smoking 
OR=1.73, 95% CI: 1.32-2.4 
I²=NA 
Fair quality review showing smoking in adolescence is 
associated with increased risk of future depression. However, 
clinical measures of depression were more likely to report a 
bidirectional effect (i.e., depression also predicting smoking). 
Han et al44  




2  Early life second-hand smoking 
 
OR=1.51, 95% CI: 0.93-2.09, 
I²=0% 
Fair quality review showing that exposure to second-hand 
smoking in early life was associated with increased odds of 
depressive symptoms in cross-sectional studies. However, the 
effects in the two prospective cohort studies was non-
significant.   
Chen et al45 
(NIH = 6) 
Postpartum 
depression 
4  Prenatal smoking  
OR=2.88, 95% CI: 0.99-8.39, 
I²=89.3% 
Fair quality review showing that prenatal smoking was strongly 
associated with postpartum depression in the overall analysis 
(including retrospective and longitudinal studies), with no 
indication of publication bias. However, in the subgroup 
analysis of longitudinal studies, the effect size was similarly 
large, but fell short of statistical significance.  
Hunter et al52 
(NIH = 7) 
Incident 
schizophrenia 
6 Personal active smoking 
RR=1.99, 95% CI: 1.1-3.61, 
I²=97% 
Good quality review showing that smokers had an 
approximately doubled risk of developing schizophrenia 
relative to non-smokers. Smaller, but still significant, effects 
were found for prenatal smoking (although this analysis was 
based on retrospective reports of prenatal smoke exposure).  
Gurillo at al53 
(NIH = 4) 
Psychotic disorders 6 Smoking 
RR=2.18, 95% CI: 1.23-3.85, 
I²=97.7% 
Fair quality review showing that daily tobacco use was 
associated with a doubled risk of psychosis. Significant risk of 
publication bias was indicated, and heterogeneity was high.  
Huang et al57 




Prenatal exposure to maternal 
smoking 
OR=1.35, 95% CI: 1.2-1.52, 
I²=59.5 
Fair quality review showing that maternal smoking during 
pregnancy was associated with increased risk of ADHD in 
offspring. However, familial and genetic factors were not 







n – number of comparisons, OR – odds ratio, RR – risk ratio, NIH – quality of the study evaluated by the National Institutes of Health’s Quality Assessment Tool for Systematic Reviews and Meta-Analyses (good: 7 or 8; 





Table 4  Causal relations of smoking and mental disorders in Mendelian randomization studies 
 Outcome Sample  Exposure Main results Summary 
Wootton et al51 
Major 
depression 
 N=135,458 cases and 
344,901 controls from Wray 
et al’s GWAS35 
Lifetime smoking (126 





Smoking initiation (378 
SNPs) 
Lifetime smoking: IVW OR=1.99, 
95% CI: 1.71-2.32, p<0.001 
 
Smoking initiation:  IVW 
OR=1.54, 95% CI: 1.44-1.64, 
p<0.01 
Strong evidence to suggest causal effects of smoking on risk 
of both depression and schizophrenia. Results were highly 
consistent across sensitivity analyses testing for pleiotropy. Bi-
directional analyses also showed some evidence for 
depression and schizophrenia causally increasing odds of 
smoking behavior. Again this was consistent across more 
pleiotropy robust methods. 
Schizophrenia 
N=36,989 cases and 
113,075 controls from 
Psychiatric Genomics 
Consortium (PGC) 
Lifetime smoking:  IVW OR: 
2.27, 95% CI: 1.67-3.08, 
p<0.001 
 
Smoking initiation:  IVW 
OR=1.53, 95% CI: 1.35-1.74, 
p<0.01 
Vermeulen et al56 Bipolar disorder 
N=20,129 cases and 21,524 
controls from Stahl et al’s 
GWAS40 
Smoking initiation (378 
SNPs) 
Lifetime smoking (126 
SNPs) 
Smoking initiation:  IVW 
OR=1.46, 95% CI: 1.28-1.66, 
p<0.001 
 
Lifetime smoking:  IVW 
OR=1.72, 95% CI: 1.29-2.28, 
p<0.001 
Evidence to suggest that smoking is a causal factor in 
increased risk for bipolar disorder. This effect was consistent 
across multiple sensitivity analyses for pleiotropy. The bi-
directional effects were tested, but there was no evidence to 
suggest that bipolar disorder risk increased smoking initiation, 
heaviness, cessation or lifetime smoking. 
Treur et al58 ADHD 
N=15,548 cases diagnosed 
>18 years from Demontis et 
al’s GWAS59 
Smoking initiation (378 
SNPs)  
OR=3.72, 95% CI: 3.10-4.44, 
p<0.001 
Evidence to suggest that smoking initiation causally increased 
risk of ADHD. This was consistent across several more 
pleiotropy robust methods. However, Steiger filtering did also 
suggest some reverse causation. Furthermore, smoking 
initiation also predicted ADHD before age 13 years, when a 
biological causal effect of own smoking is implausible. This 
result, along with the Steiger filtering, suggests the instrument 
could be capturing wider risk-taking and impulsivity. Bi-
directional analyses suggested that liability to ADHD increased 
likelihood of smoking initiation and cigarettes per day. 
Gage et al55 Schizophrenia 
N=36,989 cases and 
113,075 controls from PGC 
Smoking initiation  
(4 SNPs) 
Genome-wide significant SNPs:  
IVW OR=1.73, 95% CI: 1.30-
2.25, p<0.001  
 
Relaxed p-value threshold: 
IVW OR=1.03, 95% CI: 0.97-
1.09, p=0.32 
There were very few SNPs associated with smoking initiation 
at the time when this GWAS was conducted, and resultantly 
the four SNPs used were all in the same gene. With a relaxed 
p-value threshold, there was no evidence for an effect of 
smoking on schizophrenia. Similarly, no evidence was found 














































Danish Population Registry 
(N=63,296) comprising the 
Copenhagen General 
Population Study (CGPS) 
and the Copenhagen City 
Heart Study (CCHS) 
 
Smoking heaviness 
(ever vs. never 
smokers) from 
rs1051730 genotype 
Depression: OR=0.85, 95% CI: 
0.66-1.10 
 
Antidepressants: OR=1.02, 95% 
CI: 0.93-1.13 
(for TT allele compared to CC 
allele in smokers only) 
No evidence for an interaction 
Evidence that smoking heaviness may be causally associated 
with prescription of antipsychotic use and could causally 
influence psychotic conditions. A negative control analysis in 
never smokers found no effect, suggesting that results were 
not biased by pleiotropy. There was no evidence for a causal 
effect of smoking heaviness on depression. However, analysis 
of the Danish registry was underpowered for the schizophrenia 
analysis (due to a low number of cases) and replication 
analysis conducted using PGC data was unable to separate 
smokers and non-smokers (thus failing to test for pleiotropy). 
Schizophrenia 
 
Lifetime use of 
antipsychotics 
Schizophrenia: OR=1.60, 95% 
CI: 0.74-3.47 
 
Antipsychotics: OR=1.16, 95% 
CI: 1.02-1.31  
(for TT allele compared to CC 
allele in smokers only) 
No evidence for an interaction 









recall of clinician 
diagnosis 
N=127,632 from CARTA 
Consortium, comprising 25 
studies of European 
ancestry aged ≥16 years  
Smoking heaviness in 
ever vs. current vs. 




In current smokers (OR per T 
allele): 
Depression: OR=1.00, 95% CI: 
0.95-1.05 
Anxiety: OR=1.02, 95% CI: 0.97-
1.07 
Psychological distress: 
OR=1.02, 95% CI : 0.98-1.06 
There was no evidence for an effect of rs16969968/ rs1051730 
genotype on depression, anxiety or psychological stress.  
Bjørngaard et al46 
Depression and 
anxiety 




N=53,601 from Norwegian 
HUNT study 
Smoking heaviness in 
current vs. former vs. 
never smokers from 
rs1051730 genotype 
In smokers only (OR per T 
allele): 
Anxiety: OR=1.03, 95% CI: 0.97-
1.09 
Depression: OR: 1.02, 95% CI: 
0.95-1.09 
There was evidence for an effect of rs1051730 genotype on 
anxiety when combining smokers and non-smokers, but this 
was not the case in current and former smokers, thus 
suggesting that smoking is not a cause of anxiety and 
depression. 
Lewis et al48 
Depressed 
mood at 18 
weeks of 
pregnancy 





N=6,294 from Avon 
Longitudinal Study of 
Parents and Children 
(ALSPAC) cohort 
Smoking status before 






status from rs1051730 
genotype 
For TT compared to CC in 
smokers: 
Prenatal depression: OR=0.56, 
95% CI: 0.37-0.84 




The rs1051730 genotype predicts smoking heaviness during 
pregnancy and mothers being less likely to quit. However, 
there was no clear evidence for a causal effect of smoking on 
prenatal depression, as the results of genotype given 
continued smoking during pregnancy were consistent with a 
reduced risk of reporting depressed mood per effect allele 











Table 5  Diet and prospective risk of mental disorders in meta-analyses  
 Outcome n Exposure Main results Summary 
 
Nicolaou et al62 









95% CI: 0.80-0.96, I²=15.4% 
This meta-analysis of harmonised studies found that adults following a 
healthy dietary pattern have significantly lower risk of depressive 
symptoms overtime, even when controlling for depressive symptoms at 
baseline. Small but significant positive effects were indicated from 
adherence to a Mediterranean or DASH diet, whereas the AHEI index was 
non-significant. Scores were low on review quality, probably due to this 
study been a meta-analysis of specific studies (not full systematic review). 
Alternative Healthy Eating 
Index 
OR=0.95, 
95% CI: 0.84-1.06, I²=35% 
Dietary approaches to stop 
hypertension (DASH) 
OR=0.9, 
95% CI: 0.84-0.97,I²=0% 
Lassale et al61 
(NIH = 7) 
Clinical depression or 






95% CI: 0.55-0.82, I²=33.1 
Good quality review of multiple dietary patterns which found that adhering 
to a Mediterranean diet or low inflammatory diet is associated with reduced 
depression risk in prospective studies. It should be noted that there was 
heterogeneity in all analyses, and few studies used diagnosis of 










Dietary approaches to stop 
hypertension (DASH) 
OR=0.89,  
95% CI: 0.6-1.31, I²=68.0 
7  
 
Low dietary inflammatory 
index 
OR=0.76, 
95% CI: 0.63-0.92, I²=55.3 
 
Tolkien et al63 
(NIH = 5) 
 
Clinical depression or 
depressive symptoms 
10 Pro-inflammatory diet 
OR=1.31, 95% CI: 1.2-1.44,  
I²=5.1% 
Fair quality review showing that pro-inflammatory diets are associated with 
significantly increased risk of depression/depressive symptoms, with low 
heterogeneity between studies. 
 
Molendijk et al60 




Clinical depression or 




Healthy dietary pattern OR=0.77, 95% CI: 0.69-0.84,  
I²=88.3 
Good quality review showing that healthy dietary patterns and healthy food 
groups were associated with a lower prospective risk of depressive 
symptoms. However, there was no evidence for unhealthy diet patterns or 
unhealthy food groups increasing depression risk.  Additionally, no 
significant associations between diet and depression were found in 
subgroup analyses of the few studies which controlled for baseline 
depression severity, or used diagnosis of depression as the outcome. 
Subgroup analyses further examined various individual food groups, 
finding mixed results. 
18  Healthy food groups 
OR=0.89, 95% CI: 0.83-0.95, 
I²=71.3 
10  Unhealthy dietary patterns 
OR=1.05, 95% CI: 0.99-1.12, 
I²=45.2 
7  Unhealthy food groups 























































7  Neutral food groups 
OR=0.91, 95% CI: 0.84-1.00, 
I²=42.8 
Salari- 
Moghaddam et al69 
(NIH = 7) 
 
Clinical depression or 




High dietary  
 glycaemic index 
HR=1.05, 
95% CI: 0.76-1.44, I²=86.1% 
Good quality review which failed to find prospective relationships between 
dietary glycaemic index and depression in random effect models. 
However, this was only examined in two longitudinal studies (for which 
fixed-effects analyses did observe a significant, positive relationship). 
Thus, the findings overall can neither confirm or rule-out relationships 
between dietary glycaemic index and depression. 
Hu et al68 
(NIH = 6) 
 





RR=1.30, 95% CI: 1.19-1.41, 
I²=0.00% 
Fair quality review showing that regular consumption of sugar-sweetened 
beverages is associated with greater risk of depression. However, there 
was a low number of prospective studies assessing this association, which 
also did not adequately control for broader dietary factors. 
Saghafian et al64 
(NIH = 5) 
Clinical depression or 
depressive symptoms  
 
6 Fruit intake 
RR=0.83, 95% CI: 0.71-0.98, 
I²=84.5% 
Fair quality review showing that fruit and vegetable intake is prospectively 
associated with reduced risk of depression. There was significant 
heterogeneity among studies. However, the observed associations 
between fruit and depression are inconsistent with other meta-analyses60. 7  Vegetable intake 
RR=0.86, 95% CI: 0.75-0.98, 
I²=68.1% 
, 
Zhang et al67 
(NIH = 6) 
 
Clinical depression or 
depressive symptoms  
3  
 
High meat consumption 
RR=1.13, 95%=1.03-1.24,  
I²=19.4% 
Fair quality review showing that those with highest levels of meat 
consumption are at higher risk of depression. However, there was a small 
number of studies in the pooled analysis, which combined odds ratios from 
“never vs. any” comparisons of meat consumption with studies of high vs. 
low levels of meat consumption. A larger analysis from subgroups within 
another review found no associations for meat and depression60. 
Li et al66 
(NIH = 6) 
Clinical depression or 
depressive symptoms  
3  High dietary zinc intake 
RR=0.73, 95% CI: 0.6-0.9, 
I²=0.00% 
Fair quality review indicating an inverse association between dietary zinc 
intake and future risk of depression. However, there was a low number of 
prospective studies assessing this association, which also did not control 
for other dietary factors. 
Grosso et al65 
(NIH = 4) 




Dietary n-3 PUFA 
consumption 
RR=0.85, 95% CI: 0.73-1.00, 
I²=19% 
Fair quality review supporting the hypothesis that dietary polyunsaturated 
fatty acids may lower risk of depression. Fish intake was also associated 
with reduced risk of depression, which is consistent with a subsequent 
larger analysis60. 
4  
Dietary EPA + DHA 
consumption 





n – number of comparisons, OR – odds ratio, RR – risk ratio, HR – hazard ratio, NIH – quality of the study evaluated by the National Institutes of Health’s Quality Assessment Tool for Systematic Reviews and Meta-



























Table 6  Causal relations of diet and mental disorders in Mendelian randomization studies 
 Outcome Sample Exposure Main results Summary 
Choi et al34 Major depression 












Multivitamin: OR=1.28, 95% CI: 1.11-
1.47, p=0.0006 
Tea intake: OR=0.95, 95% CI: 0.91-0.99, 
p=0.02  
Salt intake: OR=1.10, 95% CI: 1.01-1.19, 
p=0.03 
Lamb intake: OR=1.17, 95% CI: 0.95-
1.44, p=0.14 
Inconsistent diet: OR=1.15, 95% CI : 
0.87-1.53, p=0.34 
Cereal intake: OR=0.98, 95% CI: 0.94-
1.02, p=0.42 
Vitamin B: OR=1.002, 95% CI: 0.95-
1.05, p=0.93 
There was evidence to suggest that multivitamin intake 
causally increased risk of major depression at follow-up. 
This result survived Bonferroni correction for multiple 
testing. There was also nominal evidence for salt intake 
as a causal factor for depression (non-significant after 
correction for multiple testing). The only diet-related 
factor indicated as causally reducing depression risk was 
tea drinking. However, this association was non-






Table 7  Sleep activity and prospective risk of mental disorders in meta-analyses 
 Outcome n Exposure Main results Summary 
Bao et al70 
(NIH = 5) 
 
Clinical depression or 
depressive symptoms  
 
11 Sleep disturbances 
RR=1.92, 95% CI: 1.6-2.30, 
I²=10.2% 
 
Fair quality review finding that individuals with “sleep 
disturbances” (including insomnia, complaints of 
sleeping difficulties and general poor sleep quality) were 
at significantly heightened risk of developing depression, 
with low heterogeneity between studies. Sensitivity 
analyses found associations between depression and 
sleep disturbances applied to both major depressive 
disorders and general depressive symptoms.  
4 Persistent sleep disturbances 
RR=3.90, 95% CI: 2.77-5.48, 
I²=27.1% 
Zhai et al74 
(NIH = 6) 
Clinical depression or 
depressive symptoms  
7 Short sleep duration  
RR=1.31, 95% CI: 1.04-1.64, 
I²=0% 
Fair quality review indicating that both shorter and longer 
than average sleep durations are equally associated with 
significantly increased risk of depression in adults, with 
no indication of heterogeneity influencing the findings. 
5 Long sleep duration  
RR=1.42, 95% CI: 1.04-1.92, 
I²=0% 
Lee et al75 
(NIH = 8) 
 
ADHD or clinically 
significant ADHD 
symptoms 
3 Short sleep duration 
RR=2.61, 95% CI: 1.36-5.00, 
I²=83.0% 
Good quality review finding that short sleep duration is 
associated with significantly greater risk of ADHD 
overtime, in children and adults. However, there was a 
low number of total studies/participants and significant 
heterogeneity among prospective studies. 
Li et al72  
(NIH = 7) 
Clinical depression or 






RR=2.27, 95% CI: 1.89-2.71,  
I²=92.6% 
 
Good quality review showing that insomnia (although 
primarily identified by night-time symptoms) significantly 
increases the risk of depression, although with high 
heterogeneity between studies. There was also some 
indication of publication bias, but adjusting for this did 
not alter the overall findings. 
Hertenstein et 
al73 
(NIH = 7) 
All psychiatric disorders 19  
Insomnia disorders 
 
OR=2.60, 95% CI: 1.70-3.97,  
I²=96.2% 
Good quality review of studies with at least 12 months of 
follow-up reporting that individuals with insomnia 
(including presence of both day-time and night-time 
symptoms) are at greatly increased risk of developing 
psychiatric disorders. Subgroup analyses found that 
Clinical depression or 
depressive symptoms  
 
10 






n – number of comparisons, OR – odds ratio, RR – risk ratio, NIH – quality of the study evaluated by the National Institutes of Health’s Quality Assessment Tool for Systematic Reviews and Meta-










95% CI: 1.52-6.85, 
I²=96.37% 
insomnia increased the risk of depression or anxiety 
disorders by around 3-fold, whereas effects on 
psychosis risk were weaker (n=1 only, data not shown). 
There was a substantial degree of heterogeneity 









OR – odds ratio, GWAS – genome-wide association study, SNP – single nucleotide polymorphism, PGC – Psychiatric Genomics Consortium, ADHD – attention-deficit/hyperactivity disorder  
  
Table 8  Causal relations of sleep and mental disorders in Mendelian randomization studies 
 Outcome Sample Exposure Main results Summary 
Gao et al76 
ADHD 
N =20,183 cases and 35,191 
controls from Demontis et al’s 
GWAS59  
Night-time symptoms of 
insomnia 
(15-23 SNPs)  
 
OR=1.08, 95% CI: 0.88-1.34, 
p=0.46 
There was evidence to suggest that having 
insomnia increased risk for bipolar 
disorder. The same trend was observed 
for more pleiotropy robust sensitivity 
methods, but the evidence was weaker. Major depression 
N = 9,240 cases and 9,519 
controls from PGC  
OR=0.99, 95% CI: 0.69-1.40, 
p=0.94 
Schizophrenia 
N =33,426 cases and 32,541 
controls from PGC  
OR=1.14, 95% CI: 0.93-1.39, 
p=0.20 
Bipolar disorder 
N =20,129 cases and 21,524 
controls from PGC 
OR=1.79, 95% CI: 1.40-2.29,  
p<0.001 
Choi et al34 Depression 
N=431,394 from Wray et al’s 
GWAS35 
Daytime napping  
 
 
Hours of sleep  
Daytime napping: OR=1.34, 
95% CI: 1.17-1.53, p=0.00002 
 
Hours of sleep: OR=1.04, 
95% CI: 0.93-1.15, p=0.49 
There was strong evidence for an effect of 
daytime napping as a risk factor for 
depression, and this was consistent across 
sensitivity analyses and survived 
correction for multiple testing. There was 
no clear evidence for an effect of hours of 
sleep on depression risk. 
  
Sun et al39 
Bipolar disorder 
N =20,352 cases and 31,358 
controls from Stahl et al’s 
GWAS40 Device measured sleep 
time (14 SNPs) 
OR=1.05, 95% CI: 0.77-1.39, 
p=0.72 
There was no clear evidence for an effect 
of objectively measured sleep on either 
bipolar disorder or schizophrenia. 
Schizophrenia 
N =33,426 cases and 32,541 
controls from Ruderfer et al’s 
GWAS41 
































Figure 1  Lifestyle factors in the prevention and treatment of mental illness. The dashed line indicates protective benefit from either prospective meta-
analyses (P-MAs) or Mendelian randomization studies (MRs). The double-dashed line indicates protective effects supported by evidence from both 
prospective P-MAs and MRs. The solid line indicates evidence for efficacy in treatment of mental illness from MAs of randomized controlled trials (RCTs). The 
double solid line indicates convergent evidence from MRs or P-MAs with MAs of RCTs. The treble solid line indicates convergent evidence from all three (P-
MAs + MRs + MAs of RCTs). ADHD – attention-deficit/hyperactivity disorder. Note: quality and consistency of evidence presented elsewhere. 
 
 
